Nanosphere, Inc.  

(Public, NASDAQ:NSPH)   Watch this stock  
Find more results for NSPH
+0.004 (0.71%)
Sep 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.60 - 0.66
52 week 0.54 - 2.97
Open 0.66
Vol / Avg. 351,147.00/1.04M
Mkt cap 48.45M
P/E     -
Div/yield     -
EPS -0.54
Shares 76.90M
Beta 3.03
Inst. own 34%
Aug 13, 2014
NANOSPHERE INC at Canaccord Genuity Growth Conference
Aug 6, 2014
Q2 2014 Nanosphere Inc Earnings Call - Webcast
Aug 6, 2014
Q2 2014 NANOSPHERE INC Earnings Release
Jun 25, 2014
Nanosphere Inc Receives FDA Clearance for Verigene(R) Enteric Pathogens
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -375.97% -346.40%
Operating margin -362.43% -337.14%
EBITD margin - -316.83%
Return on average assets -84.73% -64.88%
Return on average equity -133.69% -81.17%
Employees 165 -
CDP Score - -


4088 Commercial Avenue
United States - Map
+1-847-4009000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Nanosphere, Inc. develops, manufactures and markets a molecular diagnostics platform, the Verigene System. The Company�s nanoparticle technology provides the ability to run multiple tests simultaneously on the same sample. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System is consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Verigene System provides for multiple tests to be performed on a single platform, including both genomic and protein assays, from a single sample. The Company developed and launched a second generation Verigene System processor (the Processor SP) that handles the same processing steps as the Original Processor and incorporates sample preparation.

Officers and directors

Sheli Z. Rosenberg Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Michael K. McGarrity President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
J. Roger Moody Jr. Chief Financial Officer, Vice President - Finance & Administration, Treasurer, Secretary
Age: 46
Bio & Compensation  - Reuters
Kenneth Bahk Ph.D. Chief Strategy Officer
Age: 40
Bio & Compensation  - Reuters
Kristopher A. Wood Director
Bio & Compensation  - Reuters
Gene S. Cartwright Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Andre de Bruin Independent Director
Age: 67
Bio & Compensation  - Reuters
Erik Holmlin Ph.D. Independent Director
Age: 46
Bio & Compensation  - Reuters
Lorin Jeffry Randall Independent Director
Age: 70
Bio & Compensation  - Reuters